1H magnetic resonance spectroscopy in dementia (Q37150637)

18 August 2017

1 reference

title

1H magnetic resonance spectroscopy in dementia (English)

1 reference

18 August 2017

0 references

0 references

1

K Kantarci

1 reference

PubMed ID

18445744

18 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

British Journal of Radiology

18 August 2017

1 reference

18 August 2017

80 Spec No 2

1 reference

18 August 2017

S146-52

1 reference

Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study

18 August 2017

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Regional metabolic alterations in Alzheimer's disease: an in vitro 1H NMR study of the hippocampus and cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Probable Alzheimer disease: diagnosis with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

1H MR spectroscopy in common dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Brain damage after coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Short TE in vivo (1)H MR spectroscopic imaging at 1.5 T: acquisition and automated spectral analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Prediction of cognitive decline in early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Proton magnetic resonance spectroscopy and magnetoencephalographic estimation of delta dipole density: a combination of techniques that may contribute to the diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Cognitive impairment: classification by 1H magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

(1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Role of increased cerebral myo-inositol in the dementia of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

MR spectroscopy of brain white matter in the prediction of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

MRS shows abnormalities before symptoms in familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

1H MRS in stroke patients with and without cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Clinical brain proton magnetic resonance spectroscopy for management of Alzheimer's and sub-cortical ischemic vascular dementia in older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Proton magnetic resonance spectroscopy in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F60346217

21 January 2018

Identifiers

DOI

10.1259/BJR/60346217

1 reference

18 August 2017

1 reference

PubMed ID

18445744